Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 70 papers

Management of bacterial and fungal infections in cirrhosis: The MDRO challenge

Fernández J, Piano S, Bartoletti M, Wey EQ.

J Hepatol 2021, 75 Suppl 1: S101–S117

DOI: 10.1016/j.jhep.2020.11.010

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis

Jalan R, D'Amico G, Trebicka J, Moreau R, Angeli P, Arroyo V.

J Hepatol 2021, 75 Suppl 1: S14–S26

DOI: 10.1016/j.jhep.2021.01.018

Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M.

J Hepatol 2021, 75 Suppl 1(Suppl 1): S49–S66

DOI: 10.1016/j.jhep.2021.01.002

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy

Iwakiri Y, Trebicka J.

JHEP Rep 2021, 3(4): 100316

DOI: 10.1016/j.jhepr.2021.100316

Biglycan: A regulator of hepatorenal inflammation and autophagy

Schulz M, Diehl V, Trebicka J, Wygrecka M, Schaefer L.

Matrix Biol 2021, 100-101: 150–161

DOI: 10.1016/j.matbio.2021.06.001

The microbiome meets nanotechnology: Opportunities and challenges in developing new diagnostic devices

Fuentes-Chust C, Parolo C, Rosati G, Rivas L, Perez-Toralla K, Simon S, de Lecuona I, Junot C, Trebicka J, Merkoçi A.

Adv Mater 2021, 33(18): e2006104

DOI: 10.1002/adma.202006104

Acute decompensation and acute-on-chronic liver failure

Ferstl P, Trebicka J.

Clin Liver Dis 2021, 25(2): 419–430

DOI: 10.1016/j.cld.2021.01.009

Liver transplantation as a cornerstone treatment for acute-on-chronic liver failure

Schulz MS, Gu W, Schnitzbauer AA, Trebicka J.

Transpl Int 2022, 35: 10108

DOI: 10.3389/ti.2022.10108

The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

Arroyo V, Angeli P, Moreau R, Jalan R, Clària J, Trebicka J, Fernández J, Gustot T, Caraceni P, Bernardi M; investigators from the EASL-CLIF Consortium, Grifols Chair and European Foundation for the Study of Chronic Liver Failure (EF-Clif).

J Hepatol. 2021, 74(3): 670–685

DOI: 10.1016/j.jhep.2020.11.048

Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure

Trebicka J, Bork P, Krag A, Arumugam M.

Nat Rev Gastroenterol Hepatol 2021, 18(3): 167–180

DOI: 10.1038/s41575-020-00376-3